Bcl-2 has been associated with both oxidative and antioxidative eects in vivo. Moreover, despite evidence that Bcl-2 is antiapoptotic by virtue of its eect on reactive oxygen species and their scavengers, Bcl-2 exerts its antiapoptotic eects even under anaerobic conditions. The reasons for the variable relationship between Bcl-2 and reactive oxygen species are not clear. The present studies demonstrate that the impact of Bcl-2 on glutathione (GSH) metabolism is cell line-dependent. Bcl-2 overproduction in PC12 cells is associated with increased functional thiol reserves, increased reductive activation of chemotherapeutic prodrugs, and GSH accumulation after treatment with N-acetylcysteine. In contrast, Bcl-2-overproducing MCF-7 breast cancer cells demonstrate neither altered GSH handling nor potentiation of chemotherapeutic prodrug reduction. These ®ndings indicate that the eects of Bcl-2 on GSH handling are millieu-dependent. This could account for the variable eects of Bcl-2 in in vivo systems. Furthermore, since our previous studies have demonstrated that reduction-dependent prodrugs may be useful chemotherapeutic agents against tumors that demonstrate altered GSH handling, screening in vitro for alteration of GSH handling may predict responsiveness of such tumors to these reduction-dependent agents.
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Keywords: oxidative stress; apoptosis; glutathione The induction and enactment of apoptosis have been associated with the generation of reactive oxygen species. In keeping with this association, overproduction of the antiapoptosis protein, Bcl-2, is associated in some systems with increased tolerance to oxidant stress (Kane et al., 1993; Albrecht et al., 1994; Tyurina et al., 1997) , an increase in the cellular content of reducing species (Kane et al., 1993) , and prevention of the release of cytochrome c from the mitochondrion (Yang et al., 1997; Kluck et al., 1997) . However, in contradistinction to these studies, others have reported antiapoptosis activity of Bcl-2 in anaerobic systems (Jacobson and Ra, 1995) and have even ascribed a pro-oxidant function to Bcl-2 (Steinman, 1995) .
Glutathione (GSH) is one of several antioxidant species the metabolism of which is thought to be altered by Bcl-2 overproduction. We have previously discussed the implications of this alteration for apoptosis induction during cancer chemotherapy with reduction-dependent agents (Cortazzo and Schor, 1996) and in the course of neurodegenerative disease (Schor et al., 1999) . We examine herein the metabolism of GSH in native and bcl-2-transfected cell lines.
Mock-and bcl-2-transfected PC12 pheochromocytoma cells were prepared and isolated as a polyclonal population as previously published (Kane et al., 1993) . Mock-and bcl-2-transfected MCF-7 human breast cancer cells were generated by electroporation (300 mV, 960 mFD) with pSFFV-neo and pSFFVbcl-2 (plasmids described in Boise et al., 1993) , respectively. Stably transfected MCF-7 clones were screened for Bcl-2 production by Western blot analysis using the N-19 anti-Bcl-2 antibody (Santa Cruz Biotechnology).
Incubation of bcl-2-transfected PC12 cells with the GSH precursor N-acetylcysteine (NAcCys; 10 mM) for up to 8 h results in a GSH level 5-times baseline (P50.002) by 4 h of treatment ( Figure 1a) . In contrast, similar incubation of mock-transfected PC12 cells results in only a 1.6-fold increase in intracellular GSH (P50.002, Student's t-test) that is apparent by 1 h and plateaus until at least 4 h of incubation. Without additional NAcCys supplementation, the GSH content of bcl-2-transfected cells declines and the dierence in GSH content between the two transfectants loses statistical signi®cance (P40.05) by 12 h after addition of NAcCys to the medium (data not shown).
Analogous treatment of mock-and bcl-2-transfected MCF-7 cells with NAcCys results in GSH content kinetics that resemble those seen with mock-transfected PC12 cells (Figure 1b ). There was no signi®cant dierence between the MCF-7 bcl-2-and mocktransfectants in this regard.
NAcCys-induced GSH accumulation could result from augmented GSH cycling in response to oxidative consumption. As such, we have examined the eects of bcl-2 transfection on the ability of PC12 cells to exchange and recycle GSH reducing equivalents (socalled`functional thiol reserves'; Hubel et al., 1997) in response to treatment with NCS, a known`consumer' of GSH. We have done this by measuring the generation of glutathionyl radical (Stoyanovsky et al., 1996) and the decline in GSH content (Langmuir et al., 1996) after a 1 h incubation with NCS. Formation of the glutathionyl radical mirrors oxidative GSH consumption (Stoyanovsky et al., 1996) .
Treatment of bcl-2-transfected PC12 cells with NCS (0.4 nmol/10 6 cells) results in the trapping of approximately 4 nmol/mg protein (P50.005, Student's t-test) of glutathionyl radical and a decline in GSH content of 1.4 nmol/mg protein (P50.0005) over 1 h (Table 1) . In sharp contrast, treatment of mock-transfected PC12 a b Figure 1 Eects of bcl-2 transfection on accumulation of GSH in tumor cells continuously incubated with N-acetylcysteine (NAcCys; 10 mM). GSH was measured for the results depicted using the method of Tietze (1969) . Independently obtained samples assayed using the Thio-Glo TM method (Langmuir et al., 1996) gave analogous results. (a) PC12 pheochromocytoma cells. Mockand bcl-2-transfected PC12 pheochromocytoma cells were prepared and isolated as a polyclonal population as previously published (Kane et al., 1993) . Four independent experiments were performed and gave comparable results. The results of duplicate determinations from one of these experiments are shown. (b) MCF-7 breast cancer cells. Mock-and bcl-2-transfected MCF-7 human breast cancer cells were generated by electroporation (300 mV, 960 mFD) with pSFFV-neo and pSFFV-bcl-2 (plasmids described in Boise et al., 1993) , respectively. Stably transfected MCF-7 clones were screened for Bcl-2 production by Western blot analysis using the N-19 anti-Bcl-2 antibody (Santa Cruz Biotechnology). The results of single determinations from each of two mock-(Neo.1-mock and Neo.2-mock) and two bcl-2-transfected (Bcl-2.1 and Bcl-2.2) clones of MCF-7 cells are shown. A second independent experiment gave comparable results cells with NCS results in no sign®cant change in the cumulative generation of glutathionyl radical or the cellular content of GSH. Parallel studies of the eect of NCS treatment on cellular protein thiol content revealed no signi®cant change in either PC12 transfectant (data not shown).
GSH accumulation in bcl-2-transfected PC12 cells is not simply the result of increased GSH synthetic capacity. We have measured the activities of the GSH synthetic enzymes glutathione reductase (GR; Carlburg and Mannervik, 1985) and g-glutamylcysteine synthetase (GCS; Seelig and Meister, 1985) in mockand bcl-2-transfected PC12 cells both before and after 4 h treatment with 10 mM NAcCys. There was no dierence between the transfectants with respect to GCS activity either in the native state or after incubation with NAcCys (Table 1) . Furthermore, the observed lower native GR activity in bcl-2-transfected PC12 cells relative to mock-transfected cells is counter to the predicted increase in GR activity hypothesized to result in increased intracellular GSH levels after bcl-2 transfection. There was no observed dierence in GR activity after NAcCys treatment between the transfectants.
The observed GSH accumulation is also not the result of decreased GSH eux from the cell. The rate of eux of GSH from native mock-and bcl-2-transfected PC12 cells was approximated by treatment of the cells with buthionine sulfoximine (BSO; 1 mM) to block new GSH synthesis, followed by timed measurement of total GSH per cell (Tietze, 1969) . There was no signi®cant dierence in the rate of decrease in the total cellular GSH content of the two transfectants after BSO treatment (Table 1) .
Our previous studies have demonstrated the paradoxical increase in sensitivity of PC12 rat pheochromocytoma cells to NCS aorded by bcl-2 transfection [Cortazzo and Schor, 1996 ; concentration inducing apoptosis in 50% of cells (EC 50 ) decreases from 40.06 to 0.01 mm]. This potentiation of NCS toxicity was abrogated by prior incubation of PC12 cells with BSO. The dierence in eect of bcl-2 transfection on GSH handling in PC12 and MCF-7 cells led us to predict that bcl-2 transfection would not potentiate and might even prevent apoptosis in MCF-7 cells treated with NCS.
As predicted, bcl-2 overexpression in MCF-7 cells did not potentiate death induced by NCS (EC 50 increases from 0.0025+0.0005 to 0.0045+0.0009 mm). The small protective eect of bcl-2 overexpression in this system did not quite reach statistical signi®cance (P between 0.05 and 0.1, Student's t-test). However, at every concentration tested, the survival of the MCF-7 bcl-2 transfectants exceeds that of the mock transfectants (data not shown). Note also that mocktransfected MCF-7 cells are tenfold more sensitive than mock-transfected PC12 cells to the eects of NCS.
In light of the accumulation of GSH seen only in bcl-2-transfected PC12 cells after incubation with NAcCys, and the concentration-dependent role of GSH in activation of NCS Beerman et al., 1977; Schor, 1992) , we hypothesized that pretreatment of bcl-2-transfected PC12 cells with NAcCys would result in further potentiation of NCS-induced apoptosis, while the response of mock-transfected PC12 cells and mock-and bcl-2-transfected MCF-7 cells to NCS would remain unaltered by NAcCys. NAcCys treatment (4 h; 10 mM) of bcl-2-transfected PC12 cells prior to treatment with NCS results in a twofold shift in the concentration-response curve of such cells in the direction of increased potency of NCS (Figure 2 ; P50.002, Student's t-test). In contrast, the concentration-response curve of bcl-2-transfected MCF-7 cells to NCS is unaected by NAcCys treatment (EC 50 s of 0.0017+0.0002 without NAcCys and 0.0018+ 0.0002 mm with NAcCys; P40.05, Student's t-test). The sensitivity to NCS of mock-transfected cells of both types is unaected by NAcCys exposure (data not shown).
The induction of apoptosis in neural cells has been hypothesized to play a role in the morphological and physiological changes associated with a variety of developmental and pathological states (Narayanan, 1997; Gelbard et al., 1997) . For many of these, reactive oxygen species (ROS) have been implicated in the disease pathogenesis itself and/or as ®nal common mediators of apoptosis Youle, 1994, 1995) . Similarly, species known to in¯uence the induction and enactment of apoptosis have been proposed as modulators of development and disease and cellular handling of ROS. ) and GSH consumption were measured during a 1 h treatment with NCS (0.4 nmol/10 6 cells). GS . was measured as its 5,5 dimethyl-1-pyrroline N-oxide-(DMPO-) trapped adduct (Stoyanovsky et al., 1996) . GSH was measured by the Thio-Glo TM method (Langmuir et al., 1996) . The activities of glutathione reductase (GR) and g-glutamylcysteine synthetase (GCS) were measured by the methods of Carlburg and Mannervik (1985) and Seeling and Meister (1985) , respectively, before and after incubation of the cells with Nacetylcystine (NAcCys; 10 mM, 4 h). The time constant for GSH eux (t eux for GSH) was measured by determination of the GSH content of the cells (Tietze, 1969) at various time points (0.5 ± 24 h) during inhibition of new GSH synthesis (BSO, 1 mM). A straight line was ®tted to a semi-log plot of the data for each of the two transfectants, and r 2 for each line is given in the Table. In all cases, statistical signi®cance of the dierences in the appropriate direction between the mock and bcl-2 transfectants was determined by one-tailed Student's t-test. For values attaining signi®cance (de®ned as P<0.05, bcl-2 transfectant vs mock transfectant), the P values are provided in the Table. NA, not applicable; ND, not determined Some studies of the eects of bcl-2 overexpression on ROS handling in neural cells have suggsted a role for Bcl-2 in increasing the tolerance of such cells to oxidant stress (Kane et al., 1993; Albrecht et al., 1994; Tyurina et al., 1997) . Conversely, some studies have proposed a pro-oxidant role for Bcl-2, and view the enrichment of the intracellular reducing potential as a compensatory, cell-generated phenomenon (Steinman, 1995) . Still others have pointed out the Bcl-2 overproduction is protective from apoptosis under near-anaerobic conditions (Jacobson and Ra, 1995) , and the GSH depletion does not abolish the protective eects of Bcl-2 (Kane et al., 1993) . The present results demonstrate the cell-dependence of the eects of Bcl-2 on GSH metabolism. The impact of Bcl-2 on the reducing potential of the cell is millieu-dependent. This may contribute to the variability of the involvement of ROS and their scavenging in the enactment and prevention of apoptosis.
The determination by the intracellular environment of the redox activity of Bcl-2 and/or the species that are produced or altered as a result of its expression is not unique. The potential for other redox-active agents, including vitamins C and E, to either potentiate or inhibit oxidation is well-documented (Halliwell and Gutteridge, 1985) .
Our studies of NCS treatment of PC12 pheochromocytoma and MCF-7 breast cancer cells demonstrate the consequences of this biochemical variability and exemplify the potential therapeutic importance of our ®ndings. We have previously reported that, unlike the case for other chemotherapeutic agents from which cells are protected by Bcl-2 (Dole et al., 1994 (Dole et al., , 1995 Teixeira et al., 1995; Bonetti et al., 1996; Beham and MacDonnell, 1996; Campos et al., 1993; Reber et al., 1998) , Bcl-2 potentiates the induction of apoptosis by the enediyne NCS (Cortazzo and Schor, 1996) . From the mechanistic standpoint, the present results suggest increased intracellular activation of NCS in bcl-2-overexpressing cells, as evidenced by increased production of the glutathionyl radical. The relatively small concentration ratio of added NCS in the bathing medium to GSH intracellularly may be deceptive, since NCS is actively taken up into cells by endocytosis and may therefore be considerably more concentrated intracellularly than extracellularly. Additional increments in NCS concentration may arise from speci®c compartmentalization of this compound within cellular organelles (Maeda, 1994) . In addition, our ®nding that the rate of turnover of GSH is higher in Bcl-2-overproducing PC12 cells than in native producers exposed to NCS implies that not only the endogenous rate of production of ROS, but also the role of GSH in and ability to compensate for consumption of reducing equivalents is aberrant in some bcl-2-overexpressing cells. This increased GSH turnover, as evidenced by increased formation of the glutathionyl radical, is not related to changes in GSH peroxidase activity, as such changes are not associated with glutathionyl radical formation (Stoyanovsky et al., 1996) . They are rather related to the nonenzymatic generation of glutathionyl radical via interaction with NCS (Stoyanovsky et al., 1996; Chin et al., 1988) . This ®nding, along with our previous observation that the downstream block in the apoptosis ®nal common pathway produced by Bcl-2 is lifted in NCS-treated cells (Schor et al., 1999) , explains the enhanced apoptotic rate in bcl-2-transfected PC12 cells treated with the reductiondependent prodrug, NCS. The exploitation by NCS of the eects of Bcl-2 on GSH handling in some cells makes NCS a potential chemotherapeutic drug for these chemoresistant tumors. However, the celldependent eects of Bcl-2 on GSH handling imply that Bcl-2 content alone could not be used as a criterion for predicting the ecacy of NCS against tumor cells.
That incubation with NAcCys accentuates the dierence in GSH handling between bcl-2-and mocktransfected PC12 cells, but not MCF-7 cells, suggests that such incubation would augment the potentiation of apoptosis in bcl-2-overexpressing PC12 cells, but not in the analogous MCF-7 cells. Indeed, our results bear this out, suggesting that an in vitro assay of GSH accumulation after NAcCys incubation might be developed to predict the likely responsiveness of a particular tumor to NCS.
These results have broader signi®cance, as well. They indicate that the redox`set-point' of a cell and the eects of Bcl-2 on it, may determine in dramatically dierent ways the implications for that cell of exposure to antimitotic, DNA cleaving, or potential apoptosisinducing agents. As our previous studies implied, the eects of such agents are likely dictated by intrinsic properties of the cell, and not by the speci®c agent used to induce the eect (Smith et al., 1998) . Eect of NAcCys (10 mM; 378C; 4 h) pretreatment on NCS sensitivity of bcl-2-transfected PC12 pheochromocytoma cells. NCS treatment (1 h; 378C) was performed on sister cultures immediately after washout of NAcCys or vehicle (no NAcCys) from the medium. Results shown represent the mean cell counts of three determinations from one of two independent and comparable experiments. We have previously demonstrated the apoptotic nature of cell death induced by NCS in many cell lines (Hartsell et al., 1995; Hartsell et al., 1996; Cortazzo and Schor, 1996) . We have also shown the equivalence of loss of adherence to the cell culture plate and apoptotic nuclear morphology in this model (Cortazzo and Schor, 1996) . The s.e.m.s of the triplicate determinations are plotted, but are smaller than the width of the symbol at each point. At all NCS concentrations except 0.04 mm, the cell counts for NAcCys incubation dier from those for vehicle incubation at the P50.002 level (Student's t-test)
